198 related articles for article (PubMed ID: 24825902)
1. Binding and function of phosphotyrosines of the Ephrin A2 (EphA2) receptor using synthetic sterile α motif (SAM) domains.
Borthakur S; Lee H; Kim S; Wang BC; Buck M
J Biol Chem; 2014 Jul; 289(28):19694-703. PubMed ID: 24825902
[TBL] [Abstract][Full Text] [Related]
2. Structural investigation of a C-terminal EphA2 receptor mutant: Does mutation affect the structure and interaction properties of the Sam domain?
Mercurio FA; Costantini S; Di Natale C; Pirone L; Guariniello S; Scognamiglio PL; Marasco D; Pedone EM; Leone M
Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1095-1104. PubMed ID: 28602916
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of the first Sam domain of Odin and binding studies with the EphA2 receptor.
Mercurio FA; Marasco D; Pirone L; Pedone EM; Pellecchia M; Leone M
Biochemistry; 2012 Mar; 51(10):2136-45. PubMed ID: 22332920
[TBL] [Abstract][Full Text] [Related]
4. Point mutations in dimerization motifs of the transmembrane domain stabilize active or inactive state of the EphA2 receptor tyrosine kinase.
Sharonov GV; Bocharov EV; Kolosov PM; Astapova MV; Arseniev AS; Feofanov AV
J Biol Chem; 2014 May; 289(21):14955-64. PubMed ID: 24733396
[TBL] [Abstract][Full Text] [Related]
5. The SAM domain inhibits EphA2 interactions in the plasma membrane.
Singh DR; Ahmed F; Paul MD; Gedam M; Pasquale EB; Hristova K
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):31-38. PubMed ID: 27776928
[TBL] [Abstract][Full Text] [Related]
6. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.
Fang WB; Brantley-Sieders DM; Hwang Y; Ham AJ; Chen J
J Biol Chem; 2008 Jun; 283(23):16017-26. PubMed ID: 18387945
[TBL] [Abstract][Full Text] [Related]
7. Human cataract mutations in EPHA2 SAM domain alter receptor stability and function.
Park JE; Son AI; Hua R; Wang L; Zhang X; Zhou R
PLoS One; 2012; 7(5):e36564. PubMed ID: 22570727
[TBL] [Abstract][Full Text] [Related]
8. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation.
Zhuang G; Hunter S; Hwang Y; Chen J
J Biol Chem; 2007 Jan; 282(4):2683-94. PubMed ID: 17135240
[TBL] [Abstract][Full Text] [Related]
9. NMR studies of a heterotypic Sam-Sam domain association: the interaction between the lipid phosphatase Ship2 and the EphA2 receptor.
Leone M; Cellitti J; Pellecchia M
Biochemistry; 2008 Dec; 47(48):12721-8. PubMed ID: 18991394
[TBL] [Abstract][Full Text] [Related]
10. Sam domain-based stapled peptides: Structural analysis and interaction studies with the Sam domains from the EphA2 receptor and the lipid phosphatase Ship2.
Mercurio FA; Pirone L; Di Natale C; Marasco D; Pedone EM; Leone M
Bioorg Chem; 2018 Oct; 80():602-610. PubMed ID: 30036816
[TBL] [Abstract][Full Text] [Related]
11. The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.
Mercurio FA; Di Natale C; Pirone L; Iannitti R; Marasco D; Pedone EM; Palumbo R; Leone M
Sci Rep; 2017 Dec; 7(1):17474. PubMed ID: 29234063
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the EphA2 receptor intracellular region by phosphomimetic negative charges in the kinase-SAM linker.
Lechtenberg BC; Gehring MP; Light TP; Horne CR; Matsumoto MW; Hristova K; Pasquale EB
Nat Commun; 2021 Dec; 12(1):7047. PubMed ID: 34857764
[TBL] [Abstract][Full Text] [Related]
13. The Sam domain of the lipid phosphatase Ship2 adopts a common model to interact with Arap3-Sam and EphA2-Sam.
Leone M; Cellitti J; Pellecchia M
BMC Struct Biol; 2009 Sep; 9():59. PubMed ID: 19765305
[TBL] [Abstract][Full Text] [Related]
14. Specificity of HCPTP variants toward EphA2 tyrosines by quantitative selected reaction monitoring.
Balasubramaniam D; Paul LN; Homan KT; Hall MC; Stauffacher CV
Protein Sci; 2011 Jul; 20(7):1172-81. PubMed ID: 21538645
[TBL] [Abstract][Full Text] [Related]
15. Design and analysis of EphA2-SAM peptide ligands: A multi-disciplinary screening approach.
Mercurio FA; Di Natale C; Pirone L; Marasco D; Calce E; Vincenzi M; Pedone EM; De Luca S; Leone M
Bioorg Chem; 2019 Mar; 84():434-443. PubMed ID: 30576907
[TBL] [Abstract][Full Text] [Related]
16. The Sam Domain of EphA2 Receptor and its Relevance to Cancer: A Novel Challenge for Drug Discovery?
Mercurio FA; Leone M
Curr Med Chem; 2016; 23(42):4718-4734. PubMed ID: 27804871
[TBL] [Abstract][Full Text] [Related]
17. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
[TBL] [Abstract][Full Text] [Related]
18. Expression and purification of the intact cytoplasmic domain of the human ephrin receptor A2 tyrosine kinase in Escherichia coli.
Zabell KM; Laurence JS; Kinch MS; Knapp DW; Stauffacher CV
Protein Expr Purif; 2006 May; 47(1):210-6. PubMed ID: 16426859
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C phosphorylates the EphA2 receptor on serine 892 in the regulatory linker connecting the kinase and SAM domains.
Gehring MP; Pasquale EB
Cell Signal; 2020 Sep; 73():109668. PubMed ID: 32413552
[TBL] [Abstract][Full Text] [Related]
20. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade.
Pratt RL; Kinch MS
Oncogene; 2002 Oct; 21(50):7690-9. PubMed ID: 12400011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
